New England Biolabs

New England Biolabs New England Biolabs, Inc. (NEB) is an industry leader in the discovery & production of enzymes. Established in the mid 1970's, New England Biolabs, Inc.

(NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analys

is. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and subsidiaries located in Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore, South Korea and the UK. For more information about New England Biolabs visit www.neb.com. We welcome you to our Facebook community and we ask that you please follow our community guidelines, you can find them here: https://www.neb.com/community-guidelines

Durham University, NEB, and University of Glasgow researchers present 12 new bacteriophage species targeting E. coli, pr...
09/01/2026

Durham University, NEB, and University of Glasgow researchers present 12 new bacteriophage species targeting E. coli, providing a standardized set of phages to use for the analysis of phage defense systems.

Widespread antibiotic use has led to rising rates of antibiotic resistance. It is estimated that deaths from antibiotic-resistant bacterial infections will outpace deaths from cancer by 2050. Alternate methods of treatment are required. Bacteriophages (phages), are viruses that specifically target b...

In our latest podcast (https://nebiolabs.com/4xq7Syq), NEB scientists Anagha Kadam, Ph.D., and Jack Martz, M.S., talk al...
08/28/2026

In our latest podcast (https://nebiolabs.com/4xq7Syq), NEB scientists Anagha Kadam, Ph.D., and Jack Martz, M.S., talk all things RNA isolation, including different ways to isolate RNA, how silica columns perform compared to magnetic beads, and how to prevent RNase activity to ensure your next RNA isolation is a success.

08/26/2026

The biochemical origin and precise chemical structure of 5-arabinosylcytosine, a cytosine DNA hypermodification, is revealed in a Nucleic Acids Research publication by NEB, National Research Council Canada, and Brock University scientists:

Learn about exciting R&D trends in peptide therapeutics, including what makes custom mRNA display libraries so powerful,...
08/25/2026

Learn about exciting R&D trends in peptide therapeutics, including what makes custom mRNA display libraries so powerful, in this Q&A with the founders of PeptiFinder Biotech:

In this Q&A, PeptiFinder Biotech scientists share how mRNA display yields the most potent peptide binder hits, where they see the field going, and what could expand the chemical space accessible to mRNA display.

In a collaboration between Fred Hutchinson Cancer Center, Seattle University, NEB and other labs, a Nucleic Acids Resear...
08/24/2026

In a collaboration between Fred Hutchinson Cancer Center, Seattle University, NEB and other labs, a Nucleic Acids Research paper shows a subcomplex of three BREX proteins, demonstrating that BrxC is a DNA-binding ATPase that can switch between multimer forms.

Abstract. Bacteriophage exclusion (BREX) defense systems restrict phage infection via inhibition of phage DNA replication, while also modifying and protect

08/21/2026

Bioinformatic searches identified a new toxin-antitoxin system in M. tuberculosis that researchers from Universite de Toulouse, Durham University, NIH, and NEB have named RelSI. When released, the toxin cleaves the 16S rRNA and removes the anti-Shine-Dalgarno region. , [tags for X] https://academic.oup.com/nar/article/54/12/gkag571/8713020

Our Molecular Biology Summer Workshop, hosted at Quinnipiac University, took place at the end of July! Read more about t...
08/19/2026

Our Molecular Biology Summer Workshop, hosted at Quinnipiac University, took place at the end of July! Read more about the workshop and view photo highlights from the 2-week intensive in Quinnipiac Today: https://nebiolabs.com/4qnPjIx

During a two-week intensive at Quinnipiac, the New England Biolabs® (NEB®) Molecular Biology Summer Workshop brought together participants from a wide range of professional and academic backgrounds. With no prior experience required, the program fast-tracked their knowledge of foundational theory ...

Neuroinflammation is a shared hallmark of Alzheimer's, Parkinson's, and multiple sclerosis, all of which involve blood–b...
08/17/2026

Neuroinflammation is a shared hallmark of Alzheimer's, Parkinson's, and multiple sclerosis, all of which involve blood–brain barrier breakdown that admits peripheral immune cells into the CNS. SRM University, AP, CSIR - Indian Institute of Chemical Biology, Jadavpur University, University of South Florida, and NEB researchers present an end-to-end framework to identify cell-specific protein markers commonly regulated across mild-moderate AD, early-stage PD, and MS in peripheral blood mononuclear cells. This framework selects candidates by shared differential expression, filters for BBB permeability, and maps them to neural cell types. Astrocyte- and monocyte-like PBMC populations showed transcriptional and functional convergence with macrophages and neuroglia, and pathway analysis flagged kinase–integrin interactions as key regulators. Seed markers, mainly kinases and immunoglobulins, were then assessed for druggable structural features and moonlighting behavior, giving a strategy for immune-based diagnostic and therapeutic target discovery.

Neuroinflammation is a key hallmark of both neurodegenerative and neurospecific autoimmune diseases, including multiple sclerosis (MS), where immune dysregulation contributes to cellular stress, autophagy, and disease progression in Alzheimer’s disease (AD), Parkinson’s disease (PD), and MS. Eme...

In an ACS Synthetic Biology paper, NEB scientists present a microfluidic workflow that couples reconstituted in vitro tr...
08/13/2026

In an ACS Synthetic Biology paper, NEB scientists present a microfluidic workflow that couples reconstituted in vitro transcription–translation with ultrahigh-throughput droplet screening to directly link genotype and phenotype within complex, heterogeneous DNA pools: https://nebiolabs.com/4fSeqj2
ACS Publications

Abstract. We present a microfluidic workflow that couples reconstituted in vitro transcription–translation (IVTT) with ultrahigh-throughput droplet screeni

Address

240 County Road
Ipswich, MA
01938

Opening Hours

Monday 9am - 8pm
Tuesday 9am - 8pm
Wednesday 9am - 8pm
Thursday 9am - 8pm
Friday 9am - 8pm

Telephone

+18006325227

Alerts

Be the first to know and let us send you an email when New England Biolabs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to New England Biolabs:

Shortcuts

Share